US3418999A - Method of swallowing a pill - Google Patents
Method of swallowing a pill Download PDFInfo
- Publication number
- US3418999A US3418999A US344413A US34441364A US3418999A US 3418999 A US3418999 A US 3418999A US 344413 A US344413 A US 344413A US 34441364 A US34441364 A US 34441364A US 3418999 A US3418999 A US 3418999A
- Authority
- US
- United States
- Prior art keywords
- pill
- swallowing
- density
- water
- mouth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000006187 pill Substances 0.000 title description 91
- 230000009747 swallowing Effects 0.000 title description 42
- 238000000034 method Methods 0.000 title description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- 239000002775 capsule Substances 0.000 description 30
- 230000035807 sensation Effects 0.000 description 26
- 239000003826 tablet Substances 0.000 description 16
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 208000032974 Gagging Diseases 0.000 description 7
- 206010038776 Retching Diseases 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000003238 esophagus Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229920000609 methyl cellulose Polymers 0.000 description 5
- 239000001923 methylcellulose Substances 0.000 description 5
- 235000010981 methylcellulose Nutrition 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 4
- 229920003091 Methocel™ Polymers 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- -1 troches Substances 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 229940116333 ethyl lactate Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 241000167898 Hirundo rustica Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002409 epiglottis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 229940126589 solid medicine Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000152 swallowing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0061—Swallow helping devices, e.g. tongue shields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Definitions
- This invention relates to solid discrete medicinals, in any form, such as capsules, pills, tablets, troches, lozenges and pellets, for oral administration for any purpose, of any predetermined density in relation to size, to facilitate easy swallowing with water when the head is held in a bowed position.
- Swallowing a pill, or other form of solid medicine would seem to be such a basically simple procedure for those who make a practice of swallowing food, that the matter seldom comes up for consideration.
- a doctor is likely to give some such advice as Just place the pill on the back part of the tongue then take some water in the mouth, tip the head back, and SWAL- LOW!
- This procedure produces the desired result: the pill is washed down the esophagus and into the stomach.
- the pill In getting the water into the mouth, the pill may be dislodged from its strategic location on the tongue.
- the playful tongue may disobey orders and manipulate the pill into a safer corner, where gagging is not threatened.
- a bibulous pill may stick to the tongue and fail to be caught up in the stream of the swallow. Initiation of movement of the pill may occur late in the flow of the swallow, and fail to clear the throat or esophagus before the water is gone. Pill swallowing patients will eventually experience the discomfort of a pill stuck in the esophagus, and the need to drink repeatedly to dislodge it.
- FIGURE 1 is a diagrammatic view of a persons head in the process of swallowing a pill with water
- FIGURE 2 is a similar view showing a person swallowing a pill according to the present invention.
- FIGURE 3 is a graph showing the relation of volume to density of pills and tablets.
- FIGURE 1 is a cross-sectional diagram of the head of a person in the act of swallowing water with a floating type pill in the mouth when the head is tipped back as in the conventional method of swallowing.
- the pill 4 floating at the surface of the swallow of water 3 is near the front of the month away from the throat.
- the movement of the tongue may trap the pill in the roof of the month.
- the swallow of water is the wrong position to propel the pill into the throat. Then tendency of low density pills or capsules to cause swallowing difficulty with the head tipped back is therefore explained.
- FIGURE 2 shows how a pill is swallowed with water according to the present invention.
- a swallow of water 5 with a floating type pill 6 is in the mouth and the head is tipped forward in a bowed position.
- the pill floating at the surface of the water is near the throat, at the leading portion of the swallow, where the whole swallow of water is effective in carrying it through the esophagus into the stomach.
- the technique of drinking with the head in a lowered position follows the procedure used by animals, as well as by primitive man, in drinking from ponds, streams, etc.
- Drinking with the head in an upright position is a learned practice of civilized man. It carries with it the danger that liquid, or more unfortunately, solid matter, may enter the trachea, largely through the action of gravity, in case of faulty protective action of the epiglottis during the act of swallowing.
- the bowed head method of swallowing solid medicinals is therefore free of any danger of choking due to entrance of foreign matter into the trachea.
- a rate of rise of about 3 inches per second is the minimum buoyancy a pill should have to give positive floating on a swallow of water in the mouth.
- the 0.95 density line is the upper limit of demarkation of the preferred area on the density-volume graph in FIGURE 3.
- This shaded area 50 extends down to the curve 20 representing approximately the minimum density, for each size of capsule, which does not begin to give an objectionable degree of mouth sensation. A pill falling anywhere in that shaded area 50 will give good performance in swallowing by the bowed head method, with little or no mouth sensation.
- solid medicinals of all forms including capsules, pills, tablets, and the like, are formulated and fabricated to have optimum density for swallowing by the bowed head method.
- Various procedures which may be used include the following:
- a preformed pill may be coated with an adhesive solution such as gelatin, albumen, or methyl cellulose, and then dipped in any one of the above mentioned low density materials in finely divided or powder form. In order to obtain a sufficient quantity of the low density material on the surface of the pill, it may be necessary to repeat the operation.
- Another method is to coat the pill with a foamed coating based on gelatin or albumen, or methyl cellulose. A specific coating which was found to be satisfactory was prepared as follows:
- This method produced a stabilized foam, which was suitable for application as a coating to a preformed pill or tablet.
- the pills were allowed to dry at low humidity and room temperature until the surface was smooth and nontacky. Pills may be held for dipping by impaling on needles, or for more refined manufacture may be held on the end of small vacuum tubes.
- One side is dipped, the coating dried, then the pills are reversed and the remaining portion coated and dried to give a completely coated, smooth surfaced pill.
- the viscosity of the coating batch, and the resultant thickness of the coating on the pill may be controlled by controlling the temperature of the batch.
- a 2 mm. thick coating applied to a 5 grain aspirin tablet imparted very adequate buoyancy in water.
- a suitable effervescing salt is prepared from either of the following mixtures of ingredients:
- a solution for adhering the above elfervescing powder to the surface of a pill is prepared by dissolving sutficient methyl cellulose, Dow Chemical Company Methocel GOHG (400 cps. viscosity grade) in ethyl lactate to give a 2% solution by weight.
- the Methocel is dissolved in the ethyl lactate by heating to about 150 F.
- This solution is then cooled to about 100 F., or to a temperature that gives a suitable solution viscosity for dipping of the pills.
- the pill to be coated is immersed in or sprayed with this solution, then dried just sufficiently to present a tacky surface.
- the pill is then rolled in the effervescing powder to completely cover the tacky coating.
- pills, capsules, etc. which are suitable for use by the bowed head method of swallowing may be selected by reference to FIGURE 3.
- a capsule with a volume of 1.6 cc. should have a density of approximately 0.8 to approximately 0.9 in order to have adequate buoyancy to give positive, and rapid floating on a swallow of water, without excessive buoyancy which will give rise to mouth sensation.
- a capsule having a. volume of 0.8 cc. should have a density of approximately 0.65 to approximately 0.8.
- pill or tablet as used herein is intended to include medicinals in capsules or in the form of pills, tablets, troches, lozenges and pellets of any suitable shape.
- the method of swallowing a pill by a human subject which comprises the steps of taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeters to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, then bowing the head downwardly and forwardly while retaining said liquid and pill in the mouth, and then swallowing same while the head is held in said downwardly bowed position.
- the method of swallowing a pill by a human subject which comprises the steps of taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeter to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, retaining the liquid and pill in the mouth with closed lips while the head of the subject is held in normal upright position, then bowing the head downwardly and forwardly so that the closed lips of the subject are moved downwardly in an arc of approximately from the said upright position, then swallowing the liquid and pill while the head is retained in said downwardly bowed position.
- the method of swallowing a pill by a human subject which comprises taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeter to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, while the head is bowed downwardly and forwardly and swallowing the said liquid and pill while the head is held in said bowed position.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Description
Dec. 31, 1968 D. w. DAVIS 3,418,999
METHOD OF SWALLOWING A PILL Filed Feb. 12, 1964 Sheet of 2 3M Z0, IEWNVENTOR Dec. 31, 1968 Filed Feb. 12, 1964 DENSITY D. w. DAVIS 3,418,999
METHOD OF SWALLOWING A PILL Sheet 2 of 2 0.2 0.4- 0.6 0.8 L0 1.2 1.4 Lb 1.8
VOLUME 1NvENToR.
United States Patent 3,418,999 METHOD OF SWALLOWIN G A PILL Donald W. Davis, 7038 N. Beach Drive, Milwaukee, Wis. 53217 Filed Feb. 12, 1964, Ser. No. 344,413 3 Claims. (Cl. 128-1) ABSTRACT OF THE DISCLOSURE The invention relates to overcoming the difliculty experienced by some persons of gagging or choking while swallowing medicinal pills. This difficulty is overcome by providing pills having a density of less than 1.0 so that such pill will tend to float on water. In swallowing such pill the person takes a single swallowable amount of water in the mouth together with such pill, keeping the lips closed, then bows the head downwardly and forwardly while keeping the water and pill in the mouth, and then easily swallows same while the head is held in such downwardly bowed position without experiencing gagging or choking.
This invention relates to solid discrete medicinals, in any form, such as capsules, pills, tablets, troches, lozenges and pellets, for oral administration for any purpose, of any predetermined density in relation to size, to facilitate easy swallowing with water when the head is held in a bowed position.
Swallowing a pill, or other form of solid medicine, would seem to be such a basically simple procedure for those who make a practice of swallowing food, that the matter seldom comes up for consideration. In case a patient is puzzled or apprehensive about the matter, a doctor is likely to give some such advice as Just place the pill on the back part of the tongue then take some water in the mouth, tip the head back, and SWAL- LOW! A fortunate percentage of the time this procedure produces the desired result: the pill is washed down the esophagus and into the stomach.
It is commonly recognized, however, that due to various vitiating circumstances, this ideal result is not invariably achieved. In getting the water into the mouth, the pill may be dislodged from its strategic location on the tongue. The playful tongue may disobey orders and manipulate the pill into a safer corner, where gagging is not threatened. A bibulous pill may stick to the tongue and fail to be caught up in the stream of the swallow. Initiation of movement of the pill may occur late in the flow of the swallow, and fail to clear the throat or esophagus before the water is gone. Pill swallowing patients will eventually experience the discomfort of a pill stuck in the esophagus, and the need to drink repeatedly to dislodge it. When a pill requires a second try, the time delay is such that it may begin to disintegrate in the mouth from the action of the water. This can be most unpleasant, depending upon the nature of the preparation. There appears to be ample evidence that difliculty in swallowing any form of solid medicinals is experienced in greater or lesser degree by a great many people. Although with some patients the problem may be psychological, there appears to be good physical reasons why entirely normal patients might also be expected to have difficulty in swallowing some solid preparations.
Examination of a variety of pills, tablets, capsules, etc., prepared and offered for oral administration, has shown that these solid preparations vary widely in density. Compressed tablets tend to be high in density. Gelatin capsules tend to be low in density since they usually contain loose powders. Experimentation with pills, tablets, etc. of varying density has shown that extremely heavy pills are unpleasant to swallow, especially when of large size, because of the gagging sensation produced when the large, heavy pill contacts the back of the mouth and throat. With very low density pills, especially capsules, which readily float on the water taken into the mouth, swallowing failure may occur by the usual head tipped back method of swallowing, because the pill floats toward the trailing end of the swallow of water, away from the throat. The water then goes down alone, and the capsule is left in the mouth, or more uncomfortably, in the throat.
I have discovered that it is possible to avoid all of these swallowing difliculties by adjusting the density of the pill, capsule, etc., to a critical value in relation to its volume, so that it exhibits a controlled degree of buoyancy when immersed in water. In .conjunction with this adjusted density, the patient must use a new and novel technique for swallowing. The pill is taken into the mouth with a generous swallow of water, then instead of tipping the head back, it is tipped down and forward, as in how ing. The swallow is initiated and completed while the head is in the bowed position. With the head in this position, the capsule, pill, etc., floating at the surface of the swallow of water is near and approaching the throat as preparation is made for swallowing. Since the pill is buoyed up and supported by the water, there is very little mouth or throat contact, hence it produces little or no sensation from its presence. The tongue is helpless to move or control the position of the pill. With the weight load of water and pill on the forward part of the month, away from the throat, there is no gagging sensation. The mouth contents feel stable and comfortable. There is no critical timing of the swallowing factors about which the patient must be concerned. The swallow is easily initiated whenever the patient is ready. The floating pill is in mobile condition, and is infallibly projected into the throat by the swallowing action.
As the swallow starts, the throat opens, and the pill is in position to pass through immediately, while the throat is dilated to its maximum. The whole swallow of water is now behind the pill, in proper position to propel it through the esophagus and into the stomach. I find that with a generous swallow of water, even fairly large pills, having suitable buoyancy, can be swallowed by this bowed head method with no discomfort or apprehension, in fact, with very little sensation.
Further details and advantages of my invention will be apparent from the following specification and accompanying drawings, wherein FIGURE 1 is a diagrammatic view of a persons head in the process of swallowing a pill with water,
FIGURE 2 is a similar view showing a person swallowing a pill according to the present invention, and
FIGURE 3 is a graph showing the relation of volume to density of pills and tablets.
Referring to the drawings, FIGURE 1 is a cross-sectional diagram of the head of a person in the act of swallowing water with a floating type pill in the mouth when the head is tipped back as in the conventional method of swallowing. The pill 4 floating at the surface of the swallow of water 3 is near the front of the month away from the throat. When the swallow is initiated, the movement of the tongue may trap the pill in the roof of the month. In any case, the swallow of water is the wrong position to propel the pill into the throat. Then tendency of low density pills or capsules to cause swallowing difficulty with the head tipped back is therefore explained.
FIGURE 2 shows how a pill is swallowed with water according to the present invention. A swallow of water 5 with a floating type pill 6 is in the mouth and the head is tipped forward in a bowed position. The pill floating at the surface of the water is near the throat, at the leading portion of the swallow, where the whole swallow of water is effective in carrying it through the esophagus into the stomach.
It is to be noted that the technique of drinking with the head in a lowered position follows the procedure used by animals, as well as by primitive man, in drinking from ponds, streams, etc. Drinking with the head in an upright position is a learned practice of civilized man. It carries with it the danger that liquid, or more unfortunately, solid matter, may enter the trachea, largely through the action of gravity, in case of faulty protective action of the epiglottis during the act of swallowing. The bowed head method of swallowing solid medicinals is therefore free of any danger of choking due to entrance of foreign matter into the trachea.
Experiments were conducted using several observers who made test swallowings of gelatin capsules of various sizes which had been adjusted to selected densities by filling with calculated amounts of granuated sugar, Only the density range less than 1.0 was investigated, which represents the type of capsules which will float on water. All capsules were swallowed by the bowed head method. Observers reported the amount and type of mouth and throat sensation experienced with the various density capsules of various sizes.
It was observed that at the lower capsule densities, particularly with the larger capsules, the amount of mouth sensation increases. At some low density the degree of sensation becomes objectionable, due to the pressure of the capsule against the throat, and the resulting gagging sensation. This effect is undoubtedly due to the excessive buoyancy of very low density capsules, which makes them float partially above the surface of the swallow of water, and press against the tissues of the mouth or throat. This means that for any given size of capsule there is an optimum density range which will give suflicient buoyancy to give positive floating on the swallow of water in the mouth, but not excessive buoyancy which will give rise to mouth sensation.
I have determined the degree of mouth sensation obtained with capsules ranging in size from No. 4 (about 0.2 cc.) to No. 000 (about 1.8 cc.) and having densities ranging from 0.2 to nearly 1.0. Degree of mouth sensation has been characterized in three categories as no sensation, sensation not objectionable, and sensation objectionable. These data are shown graphically in FIG- URE 3. Curve 10 represents the approximate minimum density having no mouth sensation, curve represents the approximate minimum density having noticeable, but not very objectionable mouth sensation, and curve represents the density at, and below which, mouth sensation is very noticeable, and may be objectionable.
This graph shows that as the volume of the capsule increases, the density must increase, approaching 1.0, in order to avoid the excessive buoyancy which gives objectionable mouth sensation. The small capsules are much less critical as regards acceptable density for minimum sensation, than the large capsule. This is an understandable relationship, because of the smaller amount of sensation possible from the surface pressure from a small capsule.
From observing the rate of rise of various size and density capsules when immersed in water, I have concluded that a rate of rise of about 3 inches per second is the minimum buoyancy a pill should have to give positive floating on a swallow of water in the mouth. This corresponds to a density of about 0.95 for all the sizes of capsules tested. The 0.95 density line is the upper limit of demarkation of the preferred area on the density-volume graph in FIGURE 3. This shaded area 50 extends down to the curve 20 representing approximately the minimum density, for each size of capsule, which does not begin to give an objectionable degree of mouth sensation. A pill falling anywhere in that shaded area 50 will give good performance in swallowing by the bowed head method, with little or no mouth sensation.
According to this invention, solid medicinals of all forms, including capsules, pills, tablets, and the like, are formulated and fabricated to have optimum density for swallowing by the bowed head method. Various procedures which may be used include the following:
(1) Use of gelatin capsules filled with the proper amount of the medicinal to give the desired density. Normally this can be readily accomplished by inclusion of air with the solid material.
(2) Preparation of pills or tablets having a void in the center filled with air, or suitable low density material, to adjust the density of the tablet, etc., to the desired optimum. This can be accomplished by cementing together two preformed halves.
(3) Preparation of the pill or tablet by compounding the active ingredient with an admixture or inclusion of suitable solid low density excipient materials, in sufiicient amount to give the desired density, such as precipitated chalk, silica gel, corn starch, Irish moss, agar gel, and methyl cellulose. These materials may be added to the medicinal in sufficient amount to give the desired overall density of the pill.
(4) Application to the outside of a preformed tablet, of a low density coating, to reduce the average density to the desired value. For example, a preformed pill may be coated with an adhesive solution such as gelatin, albumen, or methyl cellulose, and then dipped in any one of the above mentioned low density materials in finely divided or powder form. In order to obtain a suficient quantity of the low density material on the surface of the pill, it may be necessary to repeat the operation. Another method is to coat the pill with a foamed coating based on gelatin or albumen, or methyl cellulose. A specific coating which was found to be satisfactory was prepared as follows:
70 grams of albumen (egg white) was beaten to a stiff foam using a high speed mechanical mixer.
A solution of 480 grams of surcose in grams water and grams corn syrup was boiled, with loss of water, until the boiling point reached 256 F. This hot solution was then slowly poured into the beaten egg white with continued mixing.
This method produced a stabilized foam, which was suitable for application as a coating to a preformed pill or tablet. After coating, the pills were allowed to dry at low humidity and room temperature until the surface was smooth and nontacky. Pills may be held for dipping by impaling on needles, or for more refined manufacture may be held on the end of small vacuum tubes. One side is dipped, the coating dried, then the pills are reversed and the remaining portion coated and dried to give a completely coated, smooth surfaced pill. As the batch of frothy coating cools it increases in viscosity, which increases the amount picked up on the surface of the pill when it is dipped. The viscosity of the coating batch, and the resultant thickness of the coating on the pill may be controlled by controlling the temperature of the batch. A 2 mm. thick coating applied to a 5 grain aspirin tablet imparted very adequate buoyancy in water.
(5) Preparation of the tablet by compounding with, or by overcoating with a system of bicarbonates admixed with citric acid or tartaric acid, which will produce effervescence when placed in water, due to the evolution of carbon dioxide. The evolved gas gives the buoyancy required to float the tablet. It is desirable to provide a coating of a water-permeable, film-forming material on the outside of the tablet to retain the gas under this exterior skin and give more stable buoyancy during swallowing. The following is an illustrative procedure:
A suitable effervescing salt is prepared from either of the following mixtures of ingredients:
Parts Sodium bicarbonate 84 Citric acid 7O Powdered sugar 80 Sodium bicarbonate 84 Tartaric acid 75 Powdered sugar 80 The ingredients of either mixture are slowly heated to 220 F. The mass becomes soft and sticky. Granulation of the mass is effected by stirring or kneading in acid resistant equipment. The mass is removed from the heat and the stirring continued until it is cool. The resulting granules are then thoroughly dried and mechanically reduced to a fine powder. The powder is protected from contact with moisture or humid air to prevent loss of effervescence when used in water.
A solution for adhering the above elfervescing powder to the surface of a pill is prepared by dissolving sutficient methyl cellulose, Dow Chemical Company Methocel GOHG (400 cps. viscosity grade) in ethyl lactate to give a 2% solution by weight. The Methocel is dissolved in the ethyl lactate by heating to about 150 F. This solution is then cooled to about 100 F., or to a temperature that gives a suitable solution viscosity for dipping of the pills. The pill to be coated is immersed in or sprayed with this solution, then dried just sufficiently to present a tacky surface. The pill is then rolled in the effervescing powder to completely cover the tacky coating. Slow drying is then used to remove most of the solvent. The pill is then given a protective exterior coating by immersing or spraying with the same solution. The solvent is now completely removed by drying. When immersed in water, the methyl cellulose coating passes water to the effervescing salt, which evolves carbon dioxide, and produces buoyancy of the pill. The gel of Methocel formed on the outside of the pill when immersed in water tends to trap the evolved carbon dioxide. This stabilizes the buoyancy of the pill for more positive performance during swallowing.
Examples of pills, capsules, etc., which are suitable for use by the bowed head method of swallowing may be selected by reference to FIGURE 3. A capsule with a volume of 1.6 cc. should have a density of approximately 0.8 to approximately 0.9 in order to have adequate buoyancy to give positive, and rapid floating on a swallow of water, without excessive buoyancy which will give rise to mouth sensation. Likewise, a capsule having a. volume of 0.8 cc. should have a density of approximately 0.65 to approximately 0.8.
It is to be understood that for each volume of capsule, pill, etc., there is a range of densities from the sensation objectionable line to the 1.0 density level, within which solid medicinals can be made which will function with the bowed head method of swallowing. For optimum results, however, it is preferred to select a density which falls within the shaded area surrounding the no sensation line. Obviously, the limiting maximum density is 1.0, but as the density of any capsule, pill, etc., approaches this value, the sluggish buoyancy may result in swallowing failure using the bowed head method.
It is therefore evident that the discovery of the bowed hea method of swallowing solid medicinals having selected density in relation to volume, provides a new and useful improvement in the technique of administering solid preparations to patients. This enables the avoidance of the troubles encountered in pill swallowing such as sticking to the tongue, lodging in the throat or esophagus, gagging and choking, need for multiple tries, and disintegration of pills held too long in the mouth, with the resultant unpleasantness. It will be a service to patients for whom pill swallowing is a difficult and most unpleasant necessity. It will be welcomed by mothers who must administer pills to children. The technique is readily learned, there is little or no sensation, hence it develops no apprehension nor resistance. This method, and the availability of suitable preparations, should be welcomed by office workers, and others who take pills with water from a bubbler type drinking fountain. This puts the head in exactly the right position for swallowing by this method, and the pill can be swallowed without attracting any attention, as when the head is tipped back.
The expression pill or tablet as used herein is intended to include medicinals in capsules or in the form of pills, tablets, troches, lozenges and pellets of any suitable shape.
I claim:
1. The method of swallowing a pill by a human subject which comprises the steps of taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeters to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, then bowing the head downwardly and forwardly while retaining said liquid and pill in the mouth, and then swallowing same while the head is held in said downwardly bowed position.
2. The method of swallowing a pill by a human subject which comprises the steps of taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeter to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, retaining the liquid and pill in the mouth with closed lips while the head of the subject is held in normal upright position, then bowing the head downwardly and forwardly so that the closed lips of the subject are moved downwardly in an arc of approximately from the said upright position, then swallowing the liquid and pill while the head is retained in said downwardly bowed position.
3. The method of swallowing a pill by a human subject which comprises taking a single swallowable amount of a liquid in the mouth together with a pill having a density in the range from about 0.4 to about 0.95, and a volume in the range from about 0.2 cubic centimeter to about 1.7 cubic centimeters, as shown by the shaded area 50 of FIGURE 3, while the head is bowed downwardly and forwardly and swallowing the said liquid and pill while the head is held in said bowed position.
References Cited UNITED STATES PATENTS 2,797,201 6/1957 Veatch et a1 16783 XR 2,841,528 7/1958 Myhre 167-82 3,012,893 12/1961 Krenzner et al. 99-134 LEWIS GOTTS, Primary Examiner.
SHEP K. ROSE, Assistant Examiner.
US. Cl. X.R. 424-14
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US344413A US3418999A (en) | 1964-02-12 | 1964-02-12 | Method of swallowing a pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US344413A US3418999A (en) | 1964-02-12 | 1964-02-12 | Method of swallowing a pill |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3418999A true US3418999A (en) | 1968-12-31 |
Family
ID=23350446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US344413A Expired - Lifetime US3418999A (en) | 1964-02-12 | 1964-02-12 | Method of swallowing a pill |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3418999A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3976764A (en) * | 1974-03-12 | 1976-08-24 | Eisai Co., Ltd. | Solid therapeutic preparation remaining in stomach |
| US4088750A (en) * | 1974-02-22 | 1978-05-09 | Burroughs Wellcome Co. | Method and preparation for increasing bioavailability of digoxin |
| US4101650A (en) * | 1977-04-06 | 1978-07-18 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Pepstatin floating minicapsules |
| US4126672A (en) * | 1976-02-04 | 1978-11-21 | Hoffmann-La Roche Inc. | Sustained release pharmaceutical capsules |
| US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
| US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
| US4198391A (en) * | 1973-07-20 | 1980-04-15 | R. P. Scherer Ltd. | Pharmaceutical compositions |
| EP0297978A3 (en) * | 1987-07-01 | 1990-01-31 | Forest Laboratories, Inc. | Floating sustained release therapeutic compositions |
| US5576019A (en) * | 1991-06-27 | 1996-11-19 | Captab 11C | Method for blinding a medication |
| US5895664A (en) * | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US20090269328A1 (en) * | 2004-06-07 | 2009-10-29 | Kazumi Ishii | Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion |
| EP2719376A1 (en) | 2012-10-12 | 2014-04-16 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| DE102014003744A1 (en) | 2014-03-10 | 2015-09-10 | Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) | Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same |
| WO2020185240A1 (en) | 2019-03-14 | 2020-09-17 | Lindbo Glen D | Avoiding gag reflex to enable swallowing pills |
| US20230225946A1 (en) * | 2020-05-25 | 2023-07-20 | Hervina Dosanjh | Dual spout pill storage and swallowing assist bottle device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2797201A (en) * | 1953-05-11 | 1957-06-25 | Standard Oil Co | Process of producing hollow particles and resulting product |
| US2841528A (en) * | 1954-09-21 | 1958-07-01 | Collett & Co As | Method of making fused tablets |
| US3012893A (en) * | 1959-01-06 | 1961-12-12 | Gen Foods Corp | Gasified confection and method of making the same |
-
1964
- 1964-02-12 US US344413A patent/US3418999A/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2797201A (en) * | 1953-05-11 | 1957-06-25 | Standard Oil Co | Process of producing hollow particles and resulting product |
| US2841528A (en) * | 1954-09-21 | 1958-07-01 | Collett & Co As | Method of making fused tablets |
| US3012893A (en) * | 1959-01-06 | 1961-12-12 | Gen Foods Corp | Gasified confection and method of making the same |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198391A (en) * | 1973-07-20 | 1980-04-15 | R. P. Scherer Ltd. | Pharmaceutical compositions |
| US4088750A (en) * | 1974-02-22 | 1978-05-09 | Burroughs Wellcome Co. | Method and preparation for increasing bioavailability of digoxin |
| US3976764A (en) * | 1974-03-12 | 1976-08-24 | Eisai Co., Ltd. | Solid therapeutic preparation remaining in stomach |
| US4126672A (en) * | 1976-02-04 | 1978-11-21 | Hoffmann-La Roche Inc. | Sustained release pharmaceutical capsules |
| US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
| US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
| US4101650A (en) * | 1977-04-06 | 1978-07-18 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Pepstatin floating minicapsules |
| EP0297978A3 (en) * | 1987-07-01 | 1990-01-31 | Forest Laboratories, Inc. | Floating sustained release therapeutic compositions |
| US5576019A (en) * | 1991-06-27 | 1996-11-19 | Captab 11C | Method for blinding a medication |
| US5895664A (en) * | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US20090269328A1 (en) * | 2004-06-07 | 2009-10-29 | Kazumi Ishii | Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion |
| US9161557B2 (en) * | 2004-06-07 | 2015-10-20 | Kureha Corporation | Dry composition for oral ingestion and gel composition prepared just before use for oral ingestion |
| EP2719376A1 (en) | 2012-10-12 | 2014-04-16 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| WO2014057026A1 (en) | 2012-10-12 | 2014-04-17 | Omya International Ag | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| US9987230B2 (en) | 2012-10-12 | 2018-06-05 | Omya International Ag | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| US9993428B2 (en) | 2012-10-12 | 2018-06-12 | Omya International Ag | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| DE102014003744A1 (en) | 2014-03-10 | 2015-09-10 | Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) | Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same |
| WO2015135613A1 (en) | 2014-03-10 | 2015-09-17 | Laboratorium Für Lebensmittelverfahrenstechnik (Fpe) Eidgenössische Technische Hochschule Zürich (Eth) | Product for oral administration in humans or animals, having microstructured, encapsulated ingredients, device for producing such a product, and method for producing said product |
| WO2020185240A1 (en) | 2019-03-14 | 2020-09-17 | Lindbo Glen D | Avoiding gag reflex to enable swallowing pills |
| US10857092B2 (en) | 2019-03-14 | 2020-12-08 | Glen D Lindbo | Avoiding gag reflex to enable swallowing pills |
| EP3946275A4 (en) * | 2019-03-14 | 2022-12-21 | Glen D. Lindbo | AVOIDING THE GAG REFLEX TO ENABLE PILLS TO BE SWALLOWED |
| US20230225946A1 (en) * | 2020-05-25 | 2023-07-20 | Hervina Dosanjh | Dual spout pill storage and swallowing assist bottle device |
| US11944591B2 (en) * | 2020-05-25 | 2024-04-02 | Hervina Dosanjh | Dual spout pill storage and swallowing assist bottle device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3418999A (en) | Method of swallowing a pill | |
| KR910004578B1 (en) | Preparation method of gastric retention granules | |
| US3184386A (en) | Prolonged action medicinal tablets | |
| US4271142A (en) | Portable liquid antacids | |
| Cannon | The mechanical factors of digestion | |
| CA1054056A (en) | Solid therapeutic preparation remaining in stomach | |
| US4587118A (en) | Dry sustained release theophylline oral formulation | |
| KR100627199B1 (en) | Mucosal delivery compositions and methods | |
| US5232704A (en) | Sustained release, bilayer buoyant dosage form | |
| Ardran et al. | A cineradiographic study of bottle feeding | |
| US4193985A (en) | Multiple-units drug dose | |
| CA1331341C (en) | Covered retard forms | |
| Wilding | Site-specific drug delivery in the gastrointestinal tract | |
| IL149421A (en) | Pharmaceutical compositions containing fed mode inducing agents | |
| PT840591E (en) | SYSTEM FOR ADMINISTRATION OF DISCRETE UNITS ORAL | |
| JPH07502763A (en) | Confectionery-like delivery system for pharmaceutical active substances | |
| Suradkar et al. | Overview on trends in development of gastroretentive drug delivery system | |
| JPS60237016A (en) | Drug dispenser | |
| US4484921A (en) | Theophylline therapy utilizing osmotic delivery | |
| US4439195A (en) | Theophylline therapy | |
| Sanjay et al. | Gastroretentive drug delivery system: Current approaches | |
| Jaimini et al. | A Review on Formulation and Evaluation of Gastroretentive Floating Tablet of Nifedipin. | |
| Gupta et al. | Effect of volume and viscosity of coadministered fluid on gastrointestinal distribution of small particles | |
| Kadam Shashikant et al. | Review on: Floating drug delivery system: An approach to oral controlled drug delivery via gastric retention | |
| JPS62207209A (en) | Gradually releasing oral preparation |